World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
111
Citations
50572
World Ranking
467
National Ranking
284

Research.com Recognitions

  • 2021 - Distinguished Fellows of the American Association of Immunologists (AAI)
  • 2019 - Member of the National Academy of Sciences
  • 2003 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

David H. Raulet is affiliated with the University of California, Berkeley in the United States. Their research primarily spans the fields of Immunology and Microbiology, with significant contributions in Medicine. Raulet's work extensively covers subfields such as Immunology, Oncology, Infectious Diseases, Molecular Biology, and Neurology.

The main topics addressed in Raulet's publications include:

  • Immune Cell Function and Interaction
  • Interferon and Immune Responses
  • CAR-T Cell Therapy Research
  • T-cell and B-cell Immunology
  • Viral Infections and Vectors
  • Cancer Immunotherapy and Biomarkers
  • Immune Cells in Cancer

They have published frequently in venues like bioRxiv (Cold Spring Harbor Laboratory), with six publications, as well as notable journals such as Nature Reviews. Immunology, Science Immunology, Cancer Cell, and Developmental Cell.

Notable recent papers include:

  • Roles of natural killer cells in immunity to cancer, and applications to immunotherapy (2022, Nature Reviews. Immunology)
  • NK cells mediate clearance of CD8 + T cell-resistant tumors in response to STING agonists (2020, Science Immunology)
  • Innate immune cells in the tumor microenvironment (2021, Cancer Cell)
  • Tumor-induced disruption of the blood-brain barrier promotes host death (2021, Developmental Cell)
  • Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I + tumors (2022, Proceedings of the National Academy of Sciences)

Frequent co-authors collaborating with Raulet include:

  • Natalie K. Wolf
  • Christopher J. Nicolai
  • K. Christopher García
  • Sarah M. McWhirter
  • Lora K. Picton

The scientist has been recognized by several awards and honors throughout their career. These include being named a Distinguished Fellow of the American Association of Immunologists (AAI) in 2021, election as a Member of the National Academy of Sciences in 2019, and being a Fellow of the American Association for the Advancement of Science (AAAS) since 2003.

Best Publications

  • Innate or Adaptive Immunity? The Example of Natural Killer Cells

    Eric Vivier;David H. Raulet;Alessandro Moretta;Michael A. Caligiuri

  • CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

    Fiona A. Harding;James G. McArthur;Jane A. Gross;David H. Raulet

  • Roles of the NKG2D immunoreceptor and its ligands

    David H. Raulet

  • The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

    Stephan Gasser;Sandra Orsulic;Eric J. Brown;David H. Raulet

  • Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

    Andreas Diefenbach;Eric R. Jensen;Amanda M. Jamieson;David H. Raulet

  • β2-Microglobulin deficient mice lack CD4 − 8 + cytolytic T cells

    Maarten Zijlstra;Mark Bix;Neil E. Simister;Janet M. Loring

  • Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

    Andreas Diefenbach;Amanda M. Jamieson;Scot D. Liu;Nilabh Shastri

  • Developmental potential and dynamic behavior of hematopoietic stem cells

    Ihor R. Lemischka;David H. Raulet;Richard C. Mulligan

  • Coordinated Induction by IL15 of a TCR-Independent NKG2D Signaling Pathway Converts CTL into Lymphokine-Activated Killer Cells in Celiac Disease

    Bertrand Meresse;Zhangguo Chen;Cezary Ciszewski;Maria Tretiakova

  • NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy

    Nadia Guerra;Ying Xim Tan;Nathalie T. Joncker;Augustine Choy

  • Regulation of Ligands for the NKG2D Activating Receptor

    David H. Raulet;Stephan Gasser;Benjamin G. Gowen;Weiwen Deng

  • The Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural Killing

    Amanda M. Jamieson;Andreas Diefenbach;Christopher W. McMahon;Na Xiong

  • Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade

    Joy Hsu;Jonathan J. Hodgins;Malvika Marathe;Chris J. Nicolai

  • Self-tolerance of natural killer cells

    David H. Raulet;Russell E. Vance

  • Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b

    Russell E. Vance;Jennifer R. Kraft;John D. Altman;Peter E. Jensen

  • Properties and Applications of Monoclonal Antibodies Directed against Determinants of the Thy-1 Locus

    Ann Marshak-Rothstein;Pamela Fink;Thomas Gridley;David H. Raulet

  • A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules

    Nadine C. Fernandez;Emmanuel Treiner;Emmanuel Treiner;Russell E. Vance;Russell E. Vance;Amanda M. Jamieson;Amanda M. Jamieson

  • Regulation of the natural killer cell receptor repertoire.

    David H. Raulet;Russell E. Vance;Christopher W. McMahon

  • MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity

    Nan-Shih Liao;Mark Bix;Maarten Zijlstra;Rudolf Jaenisch

  • The Structure, Function, and Molecular Genetics of the gamma/delta T Cell Receptor

    David H. Raulet

Frequent Co-Authors

Russell E. Vance
Russell E. Vance University of California, Berkeley
Werner Held
Werner Held University of Lausanne
Eric Vivier
Eric Vivier Aix-Marseille University
Mark Coles
Mark Coles University of Oxford
Elena Tomasello
Elena Tomasello Aix-Marseille University
Jacob E. Corn
Jacob E. Corn ETH Zurich
James P. Allison
James P. Allison The University of Texas MD Anderson Cancer Center
Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Ko Okumura
Ko Okumura Juntendo University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare pathways, including nursing and advanced practice. For those looking to broaden their clinical expertise, transitioning from FNP to acute care NP can offer specialized knowledge crucial for managing complex patient care. This transition is well-supported by flexible online programs tailored to working professionals.

Accelerated nurse practitioner programs provide an excellent opportunity for students who already hold a degree in another field but want to fast-track into advanced nursing roles. These programs focus on delivering intensive, streamlined coursework that prepares students for NP certification in a shorter period.

For individuals without a nursing background, online accelerated nursing programs for non nurses open doors to the nursing profession through comprehensive curricula designed for beginners. These programs emphasize foundational clinical skills combined with theoretical knowledge, enabling a smooth and efficient entry into the field.

Additionally, 12-month accelerated nursing programs offer one of the quickest paths to earning a Bachelor of Science in Nursing (BSN). These programs attract candidates seeking to enter nursing swiftly while maintaining quality education standards. Integrating immunology studies within these pathways can enrich your understanding of immune-related health dynamics essential for various clinical roles.

Best Scientists Citing David H. Raulet

Trending Scientists

Recently Published Articles